Integra Lifesciences Holdings (IART) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$267.9 million.
- Integra Lifesciences Holdings' Enterprise Value rose 350.85% to -$267.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$267.9 million, marking a year-over-year increase of 350.85%. This contributed to the annual value of -$273.6 million for FY2024, which is 1148.55% up from last year.
- Integra Lifesciences Holdings' Enterprise Value amounted to -$267.9 million in Q3 2025, which was up 350.85% from -$253.6 million recorded in Q2 2025.
- In the past 5 years, Integra Lifesciences Holdings' Enterprise Value registered a high of -$253.6 million during Q2 2025, and its lowest value of -$663.1 million during Q1 2024.
- Over the past 5 years, Integra Lifesciences Holdings' median Enterprise Value value was -$309.2 million (recorded in 2023), while the average stood at -$374.7 million.
- As far as peak fluctuations go, Integra Lifesciences Holdings' Enterprise Value crashed by 11573.56% in 2024, and later skyrocketed by 5878.39% in 2025.
- Quarter analysis of 5 years shows Integra Lifesciences Holdings' Enterprise Value stood at -$513.4 million in 2021, then increased by 11.06% to -$456.7 million in 2022, then surged by 32.31% to -$309.1 million in 2023, then grew by 11.49% to -$273.6 million in 2024, then increased by 2.08% to -$267.9 million in 2025.
- Its last three reported values are -$267.9 million in Q3 2025, -$253.6 million for Q2 2025, and -$273.3 million during Q1 2025.